Consequently, whether GAD1 can accelerate the progression of prostate cancer and the development of drug resistance by affecting the tumor immune microenvironment is an area worth exploring, and its implications for prostate cancer treatment are significant. The gene discussed is GAD1; the disease is neoplasm.